Global Enteric Disease Testing Market Analysis: Bacterial-, Viral-, and Parasitic Agents and Forecast to 2020

The global enteric disease testing market is estimated to reach USD 4.2 Billion in 2020, growing at a CAGR of 5.6% from 2016 to 2020, due to higher demand for molecular diagnostics worldwide. The global enteric disease testing market report focuses on the major diseases such as campylobacteriosis, salmonellosis, giardiasis, cryptosporidiosis, amebiasis, norovirus infection and clostridium difficile mediated infection. All age groups are susceptible to enteric diseases; however small children, elderly people and diseased people are at high risk of contracting infection due to weakened immune systems.

Browse Enteric Disease Testing Market by Causal Organism for Enteric Disease Type (Bacterial Agents – C. difficile, Campylobacteriosis, Cholera, E. coli, H. pylori, Salmonellosis, Shigellosis; Viral Agents – Norovirus, Rotavirus; and Parasitic Agents – Amebiasis, Cryptosporidiosis, Giardiasis) 2016-2020 report at https://www.ihealthcareanalyst.com/report/enteric-disease-testing-market/

Enteric infections enter the body through the mouth and intestinal tract and are usually spread through contaminated food and water or by contact with infected person. Intestinal infections can range from asymptomatic and mild to severe symptoms including abdominal cramps, vomiting, nausea and anorexia. Infectious enteric diseases are usually caused by a variety of bacteria, viruses and parasites when they enter the body through mouth and intestinal tract, primarily as a result of ingesting contaminated food and liquids. The diagnosis of acute gastroenteritis (AGE) caused by enteric pathogens, such as Salmonella spp., Shiga toxin–producing Escherichia coli (STEC), and Campylobacter spp., has traditionally been based on culture methods from patients with culture-confirmed infections.

The global enteric disease testing market report estimates the market size (Revenue USD million - 2013 to 2020) for market segmentation based on causal organism for enteric disease type (bacterial agents - C. difficile, Campylobacteriosis, Cholera, E. coli, H. pylori, Salmonellosis, Shigellosis; viral agents – Norovirus, Rotavirus; and parasitic agents – Amebiasis, Cryptosporidiosis, Giardiasis), and forecasts growth trends (CAGR% - 2016 to 2020). The global enteric disease testing market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global enteric disease testing market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.

Major players operating in the global enteric disease testing market and included in this report are Alere, Inc., Becton Dickinson & Company, Biomerica, Inc., bioMerieux, Bio-Rad, Cepheid, Coris BioConcept, DiaSorin, Meridian Bioscience, Inc., Quest Diagnostics, and Trinity Biotech.

To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/enteric-disease-testing-market/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Phone: (314) 500-7508
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.